We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Launches $4 Billion Cost-Savings Initiative
Pfizer has initiated a plan to trim annual costs by $4 billion within three years in the face of looming generic competition on many of its key products, as well as continuing uncertainty over its arthritis pain drugs.